Literature DB >> 29952451

Pioneer of Chinese Ophthalmology--130th Anniversary of Beijing Tongren Hospital.

Mayinuer Yusufu1, Ningli Wang1.   

Abstract

Much has been achieved in clinical and scientific research in the past 130 years by Beijing Tongren Hospital, which has evolved from an eye clinic to a comprehensive hospital with an ophthalmology department known as one of the best in China. This article presents the most historic moments and events in the development of a hospital with the largest eye care service volume. In addition, given the leading position of Tongren, the development of ophthalmology in Tongren is also the epitome of the development of modern ophthalmology in China. Beijing Institute of Ophthalmology (BIO) was established in 1959 as an affiliated institution under Tongren, aiming at carrying out applied science and basic science research, and directors of BIO have thus far served 4 terms as president of the Chinese Ophthalmological Society. In 2002, Beijing Tongren Eye Center (hereafter referred to as the Eye Center) was established to combine all the ophthalmic resources within Tongren. In 2017, the Eye Center alone had a surgical volume of 78,223, with surgeries for cataract, refractive errors, fundus, glaucoma, and corneal disease being the 5 most common, and 902,409 outpatient visits. Equipped with the leading experts and equipment, Tongren is dedicated to the battle against major eye diseases by carrying out large population-based epidemiological surveys and basic science research on pathogenesis and effective treatments, thereby making contributions to the development of the science of ophthalmology along with the delivery of eye care services in China and beyond. Copyright 2018 Asia-Pacific Academy of Ophthalmology.

Entities:  

Keywords:  Beijing Tongren Hospital; Chinese; Ophthalmology

Mesh:

Year:  2018        PMID: 29952451     DOI: 10.22608/APO.2018238

Source DB:  PubMed          Journal:  Asia Pac J Ophthalmol (Phila)        ISSN: 2162-0989


  1 in total

1.  Clinical application of oral Chinese Patent Medicines in ophthalmology: a scoping review protocol.

Authors:  Kai Xu; Xing Liao; Lina Liang; Yamin Li; Ziyang Huang; Xiaoyu Li; Wei Zhou; Qianqian Zuo
Journal:  BMJ Open       Date:  2022-06-20       Impact factor: 3.006

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.